We are pleased to announce the winners of the 2022 TTS elections. We appreciate all who took the time to cast a ballot and help shape the future of our society.
We were fortunate to have such an impressive host of transplant professionals featured on this year’s ballot, and TTS would like to thank all the candidates who agreed to stand for election.
Congratulations to all our new offciers and councilors who are listed below!
John J. Fung, M.D., Ph.D. is the Director of the UChicago Medicine Transplantation Institute. Prior to that, he served as Chairman of the Cleveland Clinic Health System Center for Transplantation, and Chief of the Division of Transplant Surgery at the University of Pittsburgh. After receiving his Ph.D. in Immunology and M.D. from the University of Chicago, he completed his transplant surgery fellowship at the University of Pittsburgh, under the guidance of Dr. Thomas Starzl. Dr. Fung has been a major contributor in all aspects of clinical transplantation, from immunosuppressive drug development (OKT3, tacrolimus, everolimus and TOL-101), increasing donor availability (DCD, living donor, organ preservation, machine perfusion, xenotransplantation), broadening access to transplantation (e.g. HIV, HBV, primary and metastatic liver diseases), advocating for fair allocation and broadening distribution and assisting in global expansion of transplantation services. He has written over 1,300 publications and book chapters and serves or has served on the Editorial Boards of 15 journals. Dr. Fung served as President of the International Liver Transplantation Society from 1997-1999. He has served on The Transplantation Society council continuously since 2002, as Councilor, Treasurer, Secretary and Vice-President. His vision for TTS includes outreach to developing countries and enhancing global alliances to improve the outcome and access to transplantation.
Medhat Askar, MD, PhD, FRCPath, is a Professor at Texas A&M College of Medicine, Director of Transplant Immunology, COVID-19 Testing and Cell Processing Laboratories at Baylor University Medical Center and Director of Clinical Laboratory Services at The National Marrow Donor Program (NMDP). Currently, Dr. Askar is Chair of TTS Education Committee, course director of the TTS Master Class and Leadership Series, Board member of the Worldwide Network for Blood & Marrow Transplantation (WBMT) and Treasurer of the Association of Medical Laboratory Immunologists. Dr. Askar served previously as TTS Councilor, President of the American Society for Histocompatibility and Immunogenetics (ASHI), President of the American College for Histocompatibility and Immunogenetics (ACHI), and a member of the Executive Committee of United Network for Organ Sharing (UNOS). During his ASHI presidency, he led restructuring the management model to save hundreds of thousands of dollars annually in management fees. He also spearheaded ASHI becoming a TTS affiliate society and established collaborations with sister societies worldwide. As TTS Treasurer, Dr. Askar will promote TTS financial sustainability and support of emerging transplant programs globally.
Professor John Forsythe has recently stepped down from the post as Medical Director for Organ and Tissue Donation and Transplantation in NHS Blood and Transplant, a position that he held through the pandemic, leading a team of senior clinicians and managers to support and sustain Donation, Retrieval and Transplant Services across the whole of the UK. He has held multiple administrative lead positions including the following: Board member NHS Quality Improvement Scotland; Chair, Scottish Transplant Group, later the Scottish Donation and Transplant Group; Chair of the Advisory committee for safety of blood tissues and organs (SaBTO) – an advisory committee to all UK health ministers; and, Board member of the Arm’s Length Body at its inauguration as NHS Blood and Transplant. Professional leadership positions: Past president British Transplantation Society; Past president European Society of Transplantation; UK representative to the EU specialist expert group on transplantation; and, UK representativeto the Council of Europe specialist donation and transplant committee. Clinical/Research John Forsythe was an abdominal transplant surgeon for over thirty years and had been clinical director of the programme in Edinburgh before taking up the role of Medical Director for the UK.
José Medina Pestana, MD, Ph.D., FRCS, is a Full Professor of Nephrology and Head of the Renal Transplant Division at the Federal University of São Paulo. He is past President of the Brazilian Organ Transplant Association and the "STALyC" in Latin America and received the honor to be the Joseph Murray Harvard Medical School visiting professor in 2012 and member of the Brazilian Academy of Medicine. He has worked on developing organ transplantation programs in every Brazilian state and other countries, like Nigeria and Ethiopia. His efforts envisioned the potential to increase the number of kidney transplants, turning the Hospital do Rim, the world's largest public transplant center, performing over 900 transplants annually, with more than 17,500 in the last 23 years. His extensive academic activities include more than 420 peer-reviewed publications and the mentorship of undergraduate students. His last challenge was facing the COVID-19 pandemia, leading the São Paulo state committee to define and apply public health policies.
David Thomson is a transplant surgeon and critical care specialist at Groote Schuur Hospital and the University of Cape Town. He completed his undergraduate training in 2002 at the University of Kwa-Zulu Natal and went on to specialise in surgery at the University of Cape Town completing his FCS(SA) in 2011 and MMed(Surgery) in 2012 and Critical Care in 2015. Awarded the Garron Caine Travelling Fellowship he attended the Harvard Centre for Surgery and Public Health, Massachusetts General Hospital and Brigham and Women’s Hospital transplant units in Boston in 2014. He currently works as a surgeon in the liver and renal transplantation and leads the critical care ECMO program supporting the heart and lung transplant teams. His interests are medical education and system improvement. He created the massive open online course Organ Donation: From Death to Life hosted on Coursera.org to improve education around organ donation and transplantation. He is the current President of the Southern African Transplantation Society and developed a report on Organ and Tissue Donation in South Africa: Creating a National Strategic Roadmap in collaboration with the International Society for Organ Donation and Procurement. He worked on the World Brain Death Project and is the lead author on the South African Guidelines for Determination of Death published in 2021. As Africa / Middle East councillor he would look to use his experience to build on The Transplantation Society’s work and improve organ donation and transplant systems in the region.
Peter Stock, MD, PhD, Professor of Surgery at the University of California, San Francisco, has long served the transplant community, and remains clinically active in pancreas, liver, and kidney transplantation. He has extensive experience in the surgeon-scientist role, with NIH funding in the areas of cellular transplantation and transplantation in the HIV-infected transplant recipient. Dr. Stock has served: TTS Education Committee (2011-1014); TTS Council/Ethics Committee (2017-2020) IPITA Councilor (2011-2015); Chair OPTN/UNOS Pancreas Committee (2006-2007), Chair OPTN/UNOS Kidney Committee (2007- 2009), SRTR liaison to UNOS Liver Committee (2012- 2014); and President of the American Society of Transplant Surgeons (2014-2015). He currently serves on the TTS COVID-19 task force, as Chair of the TTS Ethics Committee (2019- current), and on the India Relations Committee. As the US James IVth travelling surgical fellow (2000), visits to transplant programs in Australia (Sydney), South Africa (Cape Town), India (Chennai), China (Hong Kong), Korea (Seoul), and UK (Oxford) set the foundation for ongoing relationships that will facilitate moving the agenda of the TTS forward. As counselor, he wants to continue efforts in guiding the ethical translation of xenotransplantation and utilization of stem cell derived tissue to clinical practice, working towards global equity in COVID-19 vaccination and management for transplant recipients and providers, and improving access and facilitating the development of transplantation in resource constrained regions.
Dr Dominique E. Martin, MBBS, BA(Hons), PhD, is Associate Professor of Bioethics and Professionalism at Deakin University in Australia. Dominique is a bioethicist specialising in ethical issues relating to organ and tissue donation and transplantation. She has previously served as Co-Chair of the Ethics Committee of the Transplantation Society and of the Declaration of Istanbul Custodian Group. She is a leading member of the Ethics Taskforce of the International Society of Nephrology, a member of the Doha International Academy of Organ Donation, and an Associate Editor of Transplantation. Dominique has served as a consultant on ethical issues in donation and transplantation for the World Health Organization and the Australian Organ and Tissue Authority, and she was a member of the Australian National Health and Medical Research Council Organ and Tissue Working Committee.
In accordance with our bylaws we are holding a by-election for the Vice President (2022-2026) position being vacated by John Fung. We will hold a short call for nomination period (May 20 to June 3, 2022) followed by an election period from June 7 to 27, 2022.
Click the button below to see all eligible candidates.
Transplant in the Setting of Fulminant Hepatic Failure from HBV
(including HDV coinfection)
Check out the program preview available on our website!
Outcomes in Older Kidney Transplant Recipients After Prior Nonkidney Transplants #TBTRecipients of nonkidney solid organ transplants (nkSOT) are living longer, and 11%–18% will develop end stage renal disease (ESRD). While our general inclination is to treat nkSOT recipients who develop ESRD with a kidney transplant (KT), an increasing number are developing ESRD at an older age where KT may not be the most appropriate treatment. It is possible that the risk of older age and prior nkSOT might synergize to make KT too risky, but this has never been explored.
Association of Phlebotomy on Blood Product Transfusion Requirements During Liver Transplantation: An Observational Cohort Study on 1000 Cases #OpenAccess #TransplantTwitterDuring the past 2 decades, transfusion requirements have decreased drastically during orthotopic liver transplantation (OLT), and transfusion-free transplantation is nowadays increasingly common. Understanding that liberal intravenous volume loading in cirrhotic patients may have detrimental consequences is key. In contrast, phlebotomy is a method to lower central venous pressure and portal venous pressure. The objective of this study was to determine the effectiveness and safety of phlebotomy in the early phase of blood transfusion, blood loss, renal function, and mortality.
In-Person and Virtual
Max Dubernard: In Memoriam – The Legend of Lyon - Warren Breidenbach
Xenotransplantation – Implications for VCA - Robert Montgomery
Human organ and tissue transplantation will be on the agenda for the upcoming "Seventy-fifth World Health Assembly" being held from May 22-28. In advance of the assembly the Director-General issued a PDF report which may be downloaded below. TTS will make a statement addressed to the Assembly commenting on the report, endorsing WHO action and encouraging member states to continue to invest in transplantation.
As the global leader in transplantation, committed to health and life for all, The Transplantation Society expresses grave concern over the escalating violence and humanitarian crisis in Ukraine.
The protection of civilians and preservation of healthcare is imperative. TTS stands ready to support our colleagues, friends, families and patients impacted by this tragedy. As a non-State actor in official relations with the World Health Organization, we will seek collaborate with the WHO to provide our expert assistance on the Ukraine emergency
We are monitoring the situation and have setup a donation page (https://ukraine.tts.org) to collect funds to be distributed to support the maintenance of healthcare in the Ukraine and assist transplant patients as may be possible. We will also reach out to contacts to assess how we can assist to re-establish transplantation activities once the crisis has ended. TTS will match each contribution, dollar for dollar, up to $50,000 USD in total.
The Transplantation Society
740 Notre-Dame Ouest
Montréal, QC, H3C 3X6